371 related articles for article (PubMed ID: 22569184)
21. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
23. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
24. HIV-l and the microRNA-guided silencing pathway: an intricate and multifaceted encounter.
Provost P; Barat C; Plante I; Tremblay MJ
Virus Res; 2006 Nov; 121(2):107-15. PubMed ID: 16889864
[TBL] [Abstract][Full Text] [Related]
25. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
26. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
Mautino MR; Morgan RA
Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region.
Vemula SV; Veerasamy R; Ragupathy V; Biswas S; Devadas K; Hewlett I
Viruses; 2015 Feb; 7(2):543-58. PubMed ID: 25664610
[TBL] [Abstract][Full Text] [Related]
28. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.
Paik SY; Banerjea A; Chen CJ; Ye Z; Harmison GG; Schubert M
Hum Gene Ther; 1997 Jun; 8(9):1115-24. PubMed ID: 9189769
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
30. Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1).
Mancarella A; Procopio FA; Achsel T; De Crignis E; Foley BT; Corradin G; Bagni C; Pantaleo G; Graziosi C
J Gen Virol; 2019 May; 100(5):863-876. PubMed ID: 30896385
[TBL] [Abstract][Full Text] [Related]
31. Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.
Michael NL; Vahey MT; d'Arcy L; Ehrenberg PK; Mosca JD; Rappaport J; Redfield RR
J Virol; 1994 Feb; 68(2):979-87. PubMed ID: 8289399
[TBL] [Abstract][Full Text] [Related]
32. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
Chadwick DR; Lever AM
Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
[TBL] [Abstract][Full Text] [Related]
33. Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution?
Miller RH; Zimmer A; Moutot G; Mesnard JM; Chazal N
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835027
[TBL] [Abstract][Full Text] [Related]
34. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
[TBL] [Abstract][Full Text] [Related]
35. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
36. Intracellular expression of multimerized antisense TAR-Core RNAs inhibit the replication of human immunodeficiency virus type 1 in human CD4+ T lymphocytes.
Longchuan B; Jiangang Y; Guangwei D; Quanbi Z; Yiming S; Boqin Q
Chin Med Sci J; 1999 Mar; 14(1):13-6. PubMed ID: 12899377
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).
Cohli H; Fan B; Joshi RL; Ramezani A; Li X; Joshi S
Antisense Res Dev; 1994; 4(1):19-26. PubMed ID: 7914762
[TBL] [Abstract][Full Text] [Related]
38. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
39. Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.
Verma A; Rajagopalan P; Lotke R; Varghese R; Selvam D; Kundu TK; Ranga U
J Virol; 2016 Aug; 90(16):7046-7065. PubMed ID: 27194770
[TBL] [Abstract][Full Text] [Related]
40. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.
Imamichi H; Dewar RL; Adelsberger JW; Rehm CA; O'Doherty U; Paxinos EE; Fauci AS; Lane HC
Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8783-8. PubMed ID: 27432972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
